Table 2.
CFAS National Membership Survey Results for the Top 5 Items
| Item | Sum of very important and moderately important responses | Issue prevalence* | Cost* | Potential for harm* | Aggregate score (%) of issue prevalence, cost, and potential for harm | Recommended to include in Top 5 List* |
|---|---|---|---|---|---|---|
| 1. PGT | 54 (69.2) | 28 (50.91) | 55 (94.83) | 42 (73.68) | 73.1 | 40 (69.0) |
| 2. High dose gonadotropins | 49 (64.5) | 39 (70.91) | 42 (76.36) | 37 (67.27) | 71.5 | 30 (53.6) |
| 3. Assisted hatching | 49 (62.8) | 34 (59.65 | 37 (66.07) | 33 (58.93) | 61.6 | 29 (51.8) |
| 4. Immune therapy | 52 (67.5) | 17 (30.36) | 43 (78.18) | 43 (75.44) | 61.3 | 37 (66.1) |
| 5. DNA fragmentation | 54 (68.4) | 30 (54.55) | 46 (85.19) | 13 (24.07) | 54.6 | 31 (54.4) |
*Expressed as n (%) of respondents who answered “Yes,” in a yes or no question about whether the issue is prevalent, costly, has potential for harm, or should be in the top 5 list; note that respondents were able to skip questions